Epigallocatechin gallate (EGCG) and miR‑548m reduce HCV entry through repression of CD81 receptor in HCV cell models | Gamal Eldin Esmat Gamil

Epigallocatechin gallate (EGCG) and miR‑548m reduce HCV entry through repression of CD81 receptor in HCV cell models

Citation:: Shereen Ahmed El Sobky, Radwa Yehia Mekky· Nada El‑Ekiaby·, Noha Mousaad Elemam· Rana Ahmed Youness· Mohammad El‑Sayed, Mohammed Tarif Hamza, and Gamal Esmat· Ahmed Ihab Abdelaziz. "Epigallocatechin gallate (EGCG) and miR‑548m reduce HCV entry through repression of CD81 receptor in HCV cell models." Archives of Virology 164, no. 6 (2019): 1587-1595 .